NYSE:DHR

Danaher Stock Forecast, Price & News

$282.96

-4.07 (-1.42%)

(As of 01/20/2022 12:00 AM ET)

Add

Compare

Today's Range: $282.41
▼
$289.86
50-Day Range: $282.96
▼
$329.01
52-Week Range: $211.22
▼
$333.96

Volume: 2.94 million shs
Average Volume: 3.38 million shs
Market Capitalization: $202.20 billion

P/E Ratio: 35.86
Dividend Yield: 0.29%
Beta: 0.7

30 days | 90 days | 365 days | Advanced Chart

Receive DHR News and Ratings via Email

Sign-up to receive the latest news and ratings for Danaher and its competitors with MarketBeat's FREE daily newsletter.

About Danaher

Danaher Corp. operates as a medical company, which designs, manufactures, and markets professional, medical, industrial, and commercial products and services. It operates through the following segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines. The Diagnostics segment comprises of analytical instruments, reagents, consumables, software, and services that hospitals, physician's offices, reference laboratories, and other critical care settings use to diagnose disease and make treatment decisions. The Environmental & Applied Solution segment offers products and services that help protect important resources and keep global food and water supplies safe. The company was founded by Steven M. Rales and Mitchell P. Rales in 1969 and is headquartered in Washington, DC.

Peoples Financial Services Corp. Buys Danaher Corp, Goldman Sachs Group Inc, Thermo Fisher ... - Yahoo Finance
January 20, 2022 | finance.yahoo.com

Danaher (DHR) Stock Moves -0.48%: What You Should Know - Nasdaq
January 19, 2022 | nasdaq.com

Danaher (DHR) Stock Moves -0.48%: What You Should Know
January 19, 2022 | finance.yahoo.com

Danaher Co. (NYSE:DHR) Given Consensus Recommendation of "Buy" by Brokerages
January 19, 2022 | americanbankingnews.com

How Is The Market Feeling About Danaher Corporation? - Benzinga - Benzinga
January 12, 2022 | benzinga.com

Cramer's Investing Club: We're buying more of one club name and updating two others - CNBC
January 11, 2022 | cnbc.com

Danaher Stock Rating Hits 84: One To Watch - Investor's Business Daily
January 11, 2022 | investors.com

GE Picks Up New Buy Rating. Don't Wait for the Spinoffs. - Barron's
January 11, 2022 | barrons.com

What 5 Analyst Ratings Have To Say About Danaher - Benzinga - Benzinga
January 11, 2022 | benzinga.com

Danaher To Present At J.P. Morgan Healthcare Conference; Webcast At 11:15 AM ET - Nasdaq
January 11, 2022 | nasdaq.com

Danaher's Sales Are Better Than Expected. That's Good For Everyone. - Barron's
January 11, 2022 | barrons.com

Insights on the Dental Chair Global Market to 2026 - Featuring Danaher, Henry Schein and Tecnoodent Among Others - Yahoo Finance
January 11, 2022 | finance.yahoo.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Process control instruments
Sub-Industry: Industrial Conglomerates
Sector: Multi-Sector Conglomerates
Current Symbol: NYSE:DHR
Previous Symbol
CUSIP: 23585110
CIK: 313616
Web: www.danaher.com
Phone: (202) 828-0850
Fax: 202-828-0860
Employees: 69,000
Year Founded: 1984

Sales & Book Value

Annual Sales: $22.28 billion
Price / Sales: 9.07
Cash Flow: $9.53 per share
Price / Cash Flow: 29.70
Book Value: $51.39 per share
Price / Book: 5.51

Profitability

EPS (Most Recent Fiscal Year): $7.89
Net Income: $3.65 billion
Net Margins: 20.97%
Pretax Margin: 25.14%
Return on Equity: 18.32%
Return on Assets: 9.00%

Debt

Debt-to-Equity Ratio: 0.59
Current Ratio: 1.48
Quick Ratio: 1.11

Price-To-Earnings

Trailing P/E Ratio: 35.86
Forward P/E Ratio: 28.70
P/E Growth: 1.29

Miscellaneous

Outstanding Shares: 714,577,000
Free Float: 633,115,000
Market Cap: $202.20 billion
Optionable: Optionable

Company Calendar

Ex-Dividend for 10/29 Dividend: 9/29/2021
Last Earnings: 10/20/2021
Dividend Payable: 10/29/2021
Ex-Dividend for 1/28 Dividend: 12/29/2021
Today: 1/20/2022
Next Earnings (Confirmed): 1/27/2022
Dividend Payable: 1/28/2022
Fiscal Year End: 12/31/2022

Social Links

MarketRank^™

Overall MarketRank^™

2.98 out of 5 stars

Multi-Sector Conglomerates Sector

4th out of 26 stocks

Process Control Instruments Industry

2nd out of 17 stocks

3.5 Analyst's Opinion

Consensus Rating
Danaher has received a consensus rating of Buy. The company's average rating score is 2.93, and is based on 13 buy ratings, 1 hold rating, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $344.54, Danaher has a forecasted upside of 21.8% from its current price of $282.96.
Amount of Analyst Coverage
Danaher has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

5.0 Community Rank

Outperform Votes
Danaher has received 968 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Danaher has received 282 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Danaher has received 77.44% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Danaher and other stocks. Vote “Outperform” if you believe DHR will outperform the S&P 500 over the long term. Vote “Underperform” if you believe DHR will underperform the S&P 500 over the long term. You may vote once every thirty days.

2.5 Dividend Strength

Dividend Yield
Danaher has a dividend yield of 0.29%, which is in the bottom 25% of all stocks that pay dividends.
Dividend Growth
Danaher has been increasing its dividend for 5 years.
Dividend Coverage
The dividend payout ratio of Danaher is 10.65%. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, Danaher will have a dividend payout ratio of 8.18% next year. This indicates that Danaher will be able to sustain or increase its dividend.

3.3 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Danaher insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $233,160,046.00 in company stock.
Percentage Held by Insiders
11.40% of the stock of Danaher is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
82.59% of the stock of Danaher is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.6 Earnings and Valuation

Earnings Growth
Earnings for Danaher are expected to grow by 4.16% in the coming year, from $9.86 to $10.27 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Danaher is 35.86, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 14.70.
Price to Earnings Ratio vs. Sector
The P/E ratio of Danaher is 35.86, which means that it is trading at a more expensive P/E ratio than the Multi-Sector Conglomerates sector average P/E ratio of about 15.95.
Price to Earnings Growth Ratio
Danaher has a PEG Ratio of 1.29. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Danaher has a P/B Ratio of 5.51. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Danaher (NYSE:DHR) Frequently Asked Questions

Is Danaher a buy right now?: 14 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Danaher in the last year. There are currently 1 hold rating and 13 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Danaher stock.
View analyst ratings for Danaher or view top-rated stocks.
How has Danaher's stock price been impacted by Coronavirus?: Danaher's stock was trading at $139.37 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, DHR shares have increased by 103.0% and is now trading at $282.96.
View which stocks have been most impacted by COVID-19.
When is Danaher's next earnings date?: Danaher is scheduled to release its next quarterly earnings announcement on Thursday, January 27th 2022.
View our earnings forecast for Danaher.
How can I listen to Danaher's earnings call?: Danaher will be holding an earnings conference call on Thursday, January 27th at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link.
How were Danaher's earnings last quarter?: Danaher Co. (NYSE:DHR) posted its earnings results on Wednesday, October, 20th. The conglomerate reported $2.39 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $2.15 by $0.24. The conglomerate had revenue of $7.20 billion for the quarter, compared to analysts' expectations of $7 billion. Danaher had a trailing twelve-month return on equity of 18.32% and a net margin of 20.97%. The company's revenue for the quarter was up 22.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.72 EPS.
View Danaher's earnings history.
How often does Danaher pay dividends? What is the dividend yield for Danaher?: Danaher declared a quarterly dividend on Tuesday, December 7th. Stockholders of record on Thursday, December 30th will be paid a dividend of $0.21 per share on Friday, January 28th. This represents a $0.84 annualized dividend and a dividend yield of 0.30%. The ex-dividend date of this dividend is Wednesday, December 29th.
View Danaher's dividend history.
Is Danaher a good dividend stock?: Danaher pays an annual dividend of $0.84 per share and currently has a dividend yield of 0.29%. Danaher has been increasing its dividend for 5 consecutive years, indicating the company has a new, but growing committment to grow its dividend. The dividend payout ratio of Danaher is 10.65%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Danaher will have a dividend payout ratio of 8.18% next year. This indicates that Danaher will be able to sustain or increase its dividend.
View Danaher's dividend history.
What price target have analysts set for DHR?: 14 analysts have issued 1 year price objectives for Danaher's shares. Their forecasts range from $290.00 to $370.00. On average, they anticipate Danaher's share price to reach $344.54 in the next year. This suggests a possible upside of 21.8% from the stock's current price.
View analysts' price targets for Danaher or view top-rated stocks among Wall Street analysts.
Who are Danaher's key executives?: Danaher's management team includes the following people:
Rainer M. Blair, President, Chief Executive Officer & Director
Matthew R. McGrew, Chief Financial Officer & Executive Vice President (LinkedIn Profile)
Jose Carlos Gutiérrez Ramos, Chief Science Officer & Senior Vice President
Brian W. Ellis, Senior Vice President & General Counsel (LinkedIn Profile)
Joakim Weidemanis, Executive Vice President (LinkedIn Profile)
What is Rainer M. Blair's approval rating as Danaher's CEO?: 27 employees have rated Danaher CEO Rainer M. Blair on Glassdoor.com. Rainer M. Blair has an approval rating of 98% among Danaher's employees. This puts Rainer M. Blair in the top 20% of approval ratings compared to other CEOs of publicly-traded companies.
Who are some of Danaher's key competitors?: Some companies that are related to Danaher include Roper Technologies (ROP), Keysight Technologies (KEYS), AMETEK (AME), Fortive (FTV), Cognex (CGNX), Sensata Technologies (ST), MKS Instruments (MKSI), Mesa Laboratories (MLAB), Senseonics (SENS), Hurco Companies (HURC), Crawford United (CRAWA), Hickok (HICKA), Sypris Solutions (SYPR), International Isotopes (INIS) and ClearSign Technologies (CLIR).
View all of DHR's competitors.
What other stocks do shareholders of Danaher own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Danaher investors own include NVIDIA (NVDA), Home Depot (HD), Walt Disney (DIS), Johnson & Johnson (JNJ), Adobe (ADBE), Intel (INTC), Alibaba Group (BABA), Mastercard (MA), PayPal (PYPL) and AbbVie (ABBV).
What is Danaher's stock symbol?: Danaher trades on the New York Stock Exchange (NYSE) under the ticker symbol "DHR."
Who are Danaher's major shareholders?: Danaher's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Vaughan Nelson Investment Management L.P. (0.11%), Intermede Investment Partners Ltd (0.11%), Retirement Systems of Alabama (0.06%), Riverbridge Partners LLC (0.05%), Mountain Pacific Investment Advisers Inc. ID (0.04%) and Royal London Asset Management Ltd. (0.03%). Company insiders that own Danaher stock include Angela S Lalor, Angela S Lalor, Brian W Ellis, Daniel L Comas, Daniel Raskas, Donald J Ehrlich, Elias A Zerhouni, Joakim Weidemanis, John T Schwieters, Linda P Hefner, Matthew Mcgrew, Mitchell P Rales, Rainer Blair, Robert S Lutz, Teri List, Thomas Patrick Joyce Jr, Walter G Lohr, William K Daniel and William King.
View institutional ownership trends for Danaher.
Which major investors are selling Danaher stock?: DHR stock was sold by a variety of institutional investors in the last quarter, including M&G Investment Management Ltd., Intermede Investment Partners Ltd, Moody National Bank Trust Division, Parallel Advisors LLC, Riverbridge Partners LLC, Royal London Asset Management Ltd., Retirement Systems of Alabama, and IBM Retirement Fund. Company insiders that have sold Danaher company stock in the last year include Angela S Lalor, Brian W Ellis, Daniel Raskas, Elias A Zerhouni, Joakim Weidemanis, Linda P Hefner, Matthew Mcgrew, Mitchell P Rales, Robert S Lutz, Teri List, and Walter G Lohr.
View insider buying and selling activity for Danaher or view top insider-selling stocks.
Which major investors are buying Danaher stock?: DHR stock was bought by a variety of institutional investors in the last quarter, including Gateway Investment Advisers LLC, Vaughan Nelson Investment Management L.P., Stonnington Group LLC, Sumitomo Mitsui DS Asset Management Company Ltd, Aries Wealth Management, Miracle Mile Advisors LLC, Dixon Hubard Feinour & Brown Inc. VA, and DeDora Capital Inc..
View insider buying and selling activity for Danaher or or view top insider-buying stocks.
How do I buy shares of Danaher?: Shares of DHR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Danaher's stock price today?: One share of DHR stock can currently be purchased for approximately $282.96.
How much money does Danaher make?: Danaher has a market capitalization of $202.20 billion and generates $22.28 billion in revenue each year. The conglomerate earns $3.65 billion in net income (profit) each year or $7.89 on an earnings per share basis.
How many employees does Danaher have?: Danaher employs 69,000 workers across the globe.
Does Danaher have any subsidiaries?: The following companies are subsidiares of Danaher: AB SCIEX, AB Sciex Germany GmbH, AB Sciex LLC, AB Sciex LP, AB Sciex Pte Ltd., Accu-Sort Systems, Acme Cleveland Corporation, Advanced Vision Technology, American Precision Industries, Applied Biosystems, Applitek NV, Aquatic Infomatics ULC, Aquatic Informatics, Armstrong Tools, BC Distribution BV, Beckman Coulter, Beckman Coulter Australia Pty Ltd, Beckman Coulter Biotechnology (Suzhou) Co. Ltd., Beckman Coulter Biyomedikal Urunler Sanayi ve Ticaret Limited [irketi], Beckman Coulter Canada LP, Beckman Coulter Commercial Enterprise (China) Co. Ltd., Beckman Coulter France S.A.S., Beckman Coulter G.m.b.H., Beckman Coulter Genomics Inc., Beckman Coulter Hong Kong Limited, Beckman Coulter Inc., Beckman Coulter India Private Limited, Beckman Coulter International SA, Beckman Coulter International Shanghai Trading Co., Beckman Coulter Ireland Inc., Beckman Coulter K.K., Beckman Coulter Korea Ltd., Beckman Coulter Laboratory Systems (Suzhou) Co. Ltd., Beckman Coulter Limited Liability Company, Beckman Coulter Mishima KK, Beckman Coulter Nederland B.V., Beckman Coulter Nippon GK, Beckman Coulter S.L.U., Beckman Coulter Saudi Arabia Co.Ltd., Beckman Coulter Srl, Beckman Coulter Taiwan Inc., Beckman Coulter United Kingdom Limited, Beckman Coulter de Mexico S.A. de C.V., Beckman Coulter do Brasil Ltda., Beckman Finance ApS, Beckman Holdings Ltd., BioTector Analytical Systems Ltd, Biosafe S.A., Blue Software LLC, Cepheid, Cepheid AB, Cepheid Europe SAS, Cepheid GmbH, Cepheid HBDC SAS, Cepheid UK Ltd., ChemTreat, ChemTreat Inc., ChemTreat International Inc., Cispus Hong Kong Holding Limited, Cytiva, Cytiva BioProcess R&D AB, Cytiva Biotechnology (Guangzhou) Co. Ltd., Cytiva Biotechnology (Hang Zhou) Co. Ltd., Cytiva Europe GmbH, Cytiva Sweden AB, Cytiva Sweden Holding AB, DH Europe Finance II Sarl, DH Europe Finance Sarl, DH Holding Italia SRL, DH Japan Finance Sarl, DH Life Sciences LLC, DH Netherlands BV, DH Technologies Development Pte Ltd., DHKAB Company AB, DTIL Ireland Holdings Ltd., Danaher (Shanghai) Management Co. Ltd., Danaher Hong Kong Limited, Danaher Medical ApS, Delta Consolidated Industries, Devicore Medical Products Inc., Easco Hand Tools, Esko, Esko BV, Esko Finance BV, Esko Graphics BV, Esko Software BV, FHAB Company AB, Fluke, G. Lufft Mess- und Regeltechnik GmbH, GE Biopharma, Gelman Sciences Inc., Gendex, Genetix Group, Gilbarco Veeder Root, Gilzoni Ltd., Global Life Sciences Solutions Austria GmbH & Co. KG, Global Life Sciences Solutions Germany GmbH, Global Life Sciences Solutions Korea Ltd., Global Life Sciences Solutions Manufacturing UK Ltd, Global Life Sciences Solutions New Zealand, Global Life Sciences Solutions Operations UK Ltd, Global Life Sciences Solutions Singapore Pte Ltd, Global Life Sciences Solutions USA LLC, Global Life Sciences Technologies (Shanghai) Co Ltd., Global Life Sciences Technologies Japan KK, Hach Company, Hach Lange Finance GmbH, Hach Lange GmbH, Hach Lange Sàrl, Hach Sales & Services Canada LP, Hach Ultra Japan KK, Hach Water Quality Analytical Instru. (Shanghai) Co. Ltd., HemoCue AB, HyClone Laboratories LLC, Hybritech Incorporated, Hyclone Life Sciences Solutions India Private Limited, IDBS Group, IRIS International, Imaging Sciences International, Immunotech SAS, Immunotech Sro, Intabio LLC, Integrated DNA Technologies, Integrated DNA Technologies BVBA, Integrated DNA Technologies Inc., Integrated DNA Technologies Pte. Ltd., Iris International Inc., Joslyn Holding Company LLC, KVHG GmbH, KaVo, KaVo Kerr, Kaltenbach & Voigt, Keithley Instruments, Kipp & Zonen BV, Kollmorgen, Labcyte Inc., Laetus, Leica Biosystems Imaging Inc., Leica Biosystems Melbourne Pty Ltd, Leica Biosystems Newcastle Limited, Leica Biosystems Nussloch GmbH, Leica Biosystems Richmond Inc., Leica Instruments (Singapore) Pte Limited, Leica Microsystems, Leica Microsystems (UK) Limited, Leica Microsystems CMS GmbH, Leica Microsystems Cambridge Limited, Leica Microsystems IR GmbH, Leica Microsystems Inc., Leica Microsystems Limited, Leica Microsystems Ltd. Shanghai, Leica Mikrosysteme Vertrieb GmbH, Life Sciences Holdings France SAS*, Lifschultz Industries, Linx Printing Technologies, Linx Printing Technologies Limited, MDS Analytical Technologies, Marconi Data Systems, McCrometer Inc., Microtest, Molecular Devices, Molecular Devices (Austria) GmbH, Molecular Devices LLC, Navman Wireless, Navman Wireless OEM Solutions, Nihon Pall Ltd., Nihon Pall Manufacturing Limited, Nobel Biocare, OTT Hydromet Corp, Pall, Pall (Canada) ULC, Pall (China) Co. Ltd., Pall (Schweiz) GmbH, Pall Aeropower Corporation, Pall Artelis BVBA, Pall Asia Holdings Inc., Pall Australia Pty. Ltd., Pall Austria Filter Ges.m.b.h, Pall Corporation, Pall Europe Limited, Pall Filtersystems GmbH, Pall Filtration Pte. Ltd., Pall Filtration and Separations Group Inc., Pall France SAS, Pall GmbH, Pall India Pvt. Ltd., Pall International Sarl, Pall Italia Srl, Pall Korea Ltd., Pall Life Sciences Belgium BV, Pall Life Sciences Puerto Rico LLC, Pall Manufacturing UK Limited, Pall Medistad BV, Pall Netherlands BV Irish Branch, Pall Technology UK Limited, PaloDEX, Pantone LLC, Pelton & Crane, Phenomenex, Phenomenex Inc., Precision NanoSystems, QHC Ireland Finance Limited, Radiometer, Radiometer Basel AG, Radiometer K.K., Radiometer Medical ApS, Radiometer Medical Equipment (Shanghai) Co. Ltd., Radiometer Turku Oy, Raytek, Reytek Corporation, SH Switzerland Finance Sarl, Sea-Bird Electronics Inc., SenDx Medical Inc., Shanghai AB Sciex Analytical Instrument Trading Co. Ltd., Sutron, Sybron Dental Specialties, TCIL Ireland Finance Ltd., Tektronix, Thomson Industries, Tianjin Bonna-Agela Technologies Co. Ltd., Trojan Technologies, Trojan Technologies Group ULC, VSS Monitoring, Videojet Do Brasil Comércio de Equipamentos Para Codificação Industrial Ltda., Videojet Technologies (Shanghai) Co. Ltd., Videojet Technologies Europe B.V., Videojet Technologies Inc., Viridor Waste Management Limited, Vision Systems Limited, Willett International, X-Ray Optical Systems Inc., X-Rite, X-Rite Europe GmbH, X-Rite Incorporated, X-Rite Switzerland GmbH, XOS, Yukon Hong Kong Holding Limited, and Zhuhai S.E.Z. Videojet Electronics Ltd..
When was Danaher founded?: Danaher was founded in 1984.
What is Danaher's official website?: The official website for Danaher is www.danaher.com.
Where are Danaher's headquarters?: Danaher is headquartered at 2200 PENNSYLVANIA AVE. N.W SUITE 800W, WASHINGTON DC, 20037.
How can I contact Danaher?: Danaher's mailing address is 2200 PENNSYLVANIA AVE. N.W SUITE 800W, WASHINGTON DC, 20037. The conglomerate can be reached via phone at (202) 828-0850, via email at [email protected], or via fax at 202-828-0860.

This page was last updated on 1/20/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Danaher Stock Forecast, Price & News

About Danaher

Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

Company Calendar

Social Links

MarketRank™

Overall MarketRank™

3.5 Analyst's Opinion

5.0 Community Rank

Outperform Votes

Underperform Votes

Community Sentiment

2.5 Dividend Strength

3.3 Company Ownership

0.6 Earnings and Valuation

Danaher (NYSE:DHR) Frequently Asked Questions

Is Danaher a buy right now?

How has Danaher's stock price been impacted by Coronavirus?

When is Danaher's next earnings date?

How can I listen to Danaher's earnings call?

How were Danaher's earnings last quarter?

How often does Danaher pay dividends? What is the dividend yield for Danaher?

Is Danaher a good dividend stock?

What price target have analysts set for DHR?

Who are Danaher's key executives?

What is Rainer M. Blair's approval rating as Danaher's CEO?

Who are some of Danaher's key competitors?

What other stocks do shareholders of Danaher own?

What is Danaher's stock symbol?

Who are Danaher's major shareholders?

Which major investors are selling Danaher stock?

Which major investors are buying Danaher stock?

How do I buy shares of Danaher?

What is Danaher's stock price today?

How much money does Danaher make?

How many employees does Danaher have?

Does Danaher have any subsidiaries?

When was Danaher founded?

What is Danaher's official website?

Where are Danaher's headquarters?

How can I contact Danaher?

30 Days of MarketBeat All Access for $1.00

Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources

MarketRank^™

Overall MarketRank^™